There are many changes happening in France regarding Digital Health.
For more information about each topic, click on the topic to see the corresponding blog post:
- PECA: The new pathway to condtional reimbursement
- Transition from Etapes to TLS for remote monitoring
- LPPR registration for therapeutic digital solutions
- Introduction of organisational benefits.
Speakers:
Ouassim NAIET EL GAIED
Graduated pharmacist since 2016 and forme
r resident pharmacist, Ouassim holds a Master's degree in international regulatory affairs (Faculty of Pharmacy, Lille, France) and a university diploma in market access and health economics (Faculty of Pharmacy, Monastir, Tunisia).
Ouassim has a great interest for digital health for which he is developing an extensive experience. In fact, he is managing digital health related projects at MediTech Access since 2021. He was previously working at BioSerenity, where he managed early market access phases for connected medical devices in cardiology, neurology and sleep medicine. Before this, he was a global market access intern at Air Liquide Healthcare International, where he was actively involved in developing market access strategies for medical devices, such as a digital solution in oncology.”
Michel Verhasselt
Michel Verhasselt CEO and founder of Meditech Access, which he founded 2012. He holds a master's degree in business administration and health economics from the Catholic University of Lille. He has 30 years experience in the field of health economics, HTA, DRG coding and reimbursement, especially for the medical device industry, make him an expert. He conducts public affairs and market access activities for France, Belgium and Switzerland